icon
موقع حكومي رسمي تابع لحكومة المملكة العربية السعودية
icon السبت 13 جمادى الأولى 1448هـ
نسخة تجريبية
icon
روابط المواقع الالكترونية الرسمية السعودية تنتهي بـ gov.sa

جميع روابط المواقع الرسمية التابعة للجهات الحكومية في المملكة العربية السعودية تنتهي بـ .gov.sa

icon
المواقع الرسمية الآمنة تستخدم HTTPS

تحقق من أن الموقع يستخدم بروتوكول HTTPS

icon

مسجل لدى هيئة الحكومة الرقمية برقم :

20250831619
اقتراحات

قائمة الدراسات السريرية المسجلة على الادوية

عرض 251 - 260 من 518
عنوان الدراسة داعم الدراسة حالة الدراسة دواء الدراسة مرحلة الدراسة رقم بروتوكول الدراسة موقع الدراسة
An Observational Registry of Abatacept in Patients with Juvenile Idiopathic Arthritis Bristol-Myers Squibb Ongoing Abatacept 4 IM101240 King Abdulaziz Medical City NG (Riyadh)
A prospective, multicenter, observational study to evaluate patients’ quality oflife in routine clinical practice in patients with relapsing-remitting multiplesclerosis (RRMS) treated with LEMTRADA® Sanofi Ongoing alemtuzumab 4 OBS15590 Al-Noor Specialist Hospital (Makkah), King Khalid University Hospital (Riyadh), King Saud Medical City (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah)
A multicenter, multinational, prospective, observational study to describe the clinical outcomes in patients with type 2 diabetes mellitus, treated with insulin glargine 300 U/mL (insulin glargine U300) before, during and after the period of Ramadan / ORION study Sanofi Ongoing Toujeo 4 OBS16040 King Abdulaziz University Hospital (Jeddah), Alzafer Hospital (Najran), University District Hospital (Jeddah), Saudi German Hospital (Jeddah)
An observational prospective study of switching asthma patients from a fixed-dose combination (FDC) Inhaled Corticosteroids [ICS] / Long-Acting Beta-Agonists [LABA] therapy delivered by pMDI Seretide® Evohaler to ICS/LABA delivered by pMDI Flutiform® Mundipharma Ongoing Flutiform 4 FLT18-KSA King Fahad Medical City (Riyadh), Prince Sultan Military Medical City (Riyadh)
An open label, Phase IV Multicentric Single Arm Study to Assess the Safety and Efficacy of BetazoleTM Cream Containing Betamethasone dipropionate (0.05% W/W) and Miconazole nitrate (2% W/W) in Subjects with Inflamed Skin Conditions of Eczema or Dermatitis 2ry Caused by Infection With Fungi Jamjoom Pharmaceuticals Ongoing Betazole 4 BETA001 King Abdulaziz University Hospital (Jeddah), King Khalid University Hospital (Riyadh)
An open label, Phase IV, multicenter study to Assess the efficacy and safety of Elica-MTM Cream Containing Miconazole nitrate 2% w/w and Mometasone furoate 0.1% w/w) in Napkin Dermatitis with Inflamed Skin Conditions of Eczema or Dermatitis Caused by Infection With Certain Fungi and Bacteria Jamjoom Pharmaceuticals Ongoing Elica-M 4 ELICA-M001 King Abdulaziz University Hospital (Jeddah), King Khalid University Hospital (Riyadh)
REFINE: Regorafenib observational study in hepatocellular carcinoma Bayer Ongoing Stivarga (regorafenib) 4 19244 King Fahad Specialist Hospital (Dammam), King Khalid University Hospital (Riyadh),King Fahad Medical City (Riyadh),King Fahad Medical City (Riyadh),King Fahad Medical City (Riyadh), My Clinic (Jeddah)
UPDATES: A prospective non-interventional study investigating the treatment effect of Tresiba® in adult patients with type 2 diabetes in Saudi Arabia Novonordisk Ongoing Tresiba 4 NN1250-444 Dr. Soliman Fakeeh Hospital (Jeddah), Security Force Hospital (Riyadh), Umm Al-Qura University (Makkah), Dr. Sulaiman Al Habib Medical Group, King Fahad Medical City (Riyadh), Specialized Medical Center (Riyadh), Almana Hospital (Jubail), Saudi German Hospital (Jeddah), Almana Hospital (Ahsa), Almana Hospital (Khobar), Mouwasat Hospital (Qatif), Almana Hospital (Dammam), King Abdulaziz University Hospital (Jeddah), King Fahad Hospital of the University, My Clinic (Jeddah), United Doctors (Jeddah), Mouwasat Hospital (Khobar), Agrass Medical Complex (Jeddah)
Post-authorization safety study in patients with type 2 diabetes mellitus to assess the incidence of ketoacidosis, severe complications of urinary tract infection, volume depletion, and dehydration among patients treated with EMPAGLIFLOZIN or DPP-4 inhibitors in Saudi Arabia Boehringer Ingelheim Ongoing Jardiance 4 1245/149 Armed Force Hospital (Al-Hada), King Fahad Medical City (Riyadh)
MultiZonal obsERvational study conducted By clinIcal practitioners on Repatha® use iN subjects with hyperlipIdemia - ZERBINI Amgen Ongoing Repatha 4 2016.03.27 Saud Al-Babtain Cardiac Center (Dammam), King Fahd Military Medical Complex (Dhahran), King Khalid University Hospital (Riyadh), King Abdulaziz University Hospital (Jeddah), Armed Force Hospital (Taif), Armed Force Hospital (Khamis Mushait), Prince Sultan Cardic Center (Riyadh)